BioArctic Annual General Meeting 2021
May 6, 2021
BioArctic published the company’s Interim Report for the period January – March 2021 on Wednesday, April 21, 2021, at 08:00 a.m. CEST.
Halting the disease progression would lead to great benefits to patients, families and caregivers.
The medical need of treatments is high due to the lack of drugs affecting the underlying pathology.
BioArctic is committed to help people with neurodegenerative disorders
BioArctic AB, Warfvinges väg 35, SE-112 51 Stockholm, Sweden. Phone: +46 8 695 69 30. E-mail: firstname.lastname@example.org. Registration number: 556601-2679.
© 2021 BioArctic AB – All rights reserved